Marshall Wace, LLP Frequency Therapeutics, Inc. Transaction History

Marshall Wace, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.44 - $5.47 $29,959 - $372,446	68,089 New	68,089 $34,000
Q1 2021 May 17, 2021	SELL	$7.99 - $55.01 $125,139 - $861,566	-15,662 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$18.65 - $40.0 $292,096 - $626,480	15,662 New	15,662 $553,000
Q2 2020 Aug 13, 2020	SELL	$14.65 - $24.9 $30,691 - $52,165	-2,095 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$16.36 - $27.55 $542,121 - $912,924	-33,137 Reduced 94.05%	2,095 $37,000
Q4 2019 Feb 14, 2020	BUY	$12.67 - $18.73 $446,389 - $659,895	35,232 New	35,232 $618,000

Ticker FREQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,262,000
Description
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.